Achieve Life Sciences, Inc. SP4P.F Stock
Achieve Life Sciences, Inc. Price Chart
Achieve Life Sciences, Inc. SP4P.F Financial and Trading Overview
| Achieve Life Sciences, Inc. stock price | 4.62 EUR |
| Previous Close | 5.75 EUR |
| Open | 5.35 EUR |
| Bid | 5.3 EUR x N/A |
| Ask | 5.5 EUR x N/A |
| Day's Range | 5.35 - 5.35 EUR |
| 52 Week Range | 1.99 - 8.95 EUR |
| Volume | 1.02K EUR |
| Avg. Volume | 61 EUR |
| Market Cap | 119.51M EUR |
| Beta (5Y Monthly) | 1.562676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.16 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 36.71 EUR |
SP4P.F Valuation Measures
| Enterprise Value | 99.19M EUR |
| Trailing P/E | N/A |
| Forward P/E | -1.5875372 |
| PEG Ratio (5 yr expected) | -0.12 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 214 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.366 |
Trading Information
Achieve Life Sciences, Inc. Stock Price History
| Beta (5Y Monthly) | 1.562676 |
| 52-Week Change | 3.77% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.95 EUR |
| 52 Week Low | 1.99 EUR |
| 50-Day Moving Average | 6.52 EUR |
| 200-Day Moving Average | 4.25 EUR |
SP4P.F Share Statistics
| Avg. Volume (3 month) | 61 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 21.04M |
| Float | 17.86M |
| Short Ratio | N/A |
| % Held by Insiders | 8.50% |
| % Held by Institutions | 33.13% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -85.79% |
| Return on Equity (ttm) | -400.15% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -41918000 EUR |
| Net Income Avi to Common (ttm) | -43769000 EUR |
| Diluted EPS (ttm) | -3.44 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.51M EUR |
| Total Cash Per Share (mrq) | 0.92 EUR |
| Total Debt (mrq) | 16.48M EUR |
| Total Debt/Equity (mrq) | 3720.77 EUR |
| Current Ratio (mrq) | 0.898 |
| Book Value Per Share (mrq) | 0.025 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -39073000 EUR |
| Levered Free Cash Flow (ttm) | -24266124 EUR |
Profile of Achieve Life Sciences, Inc.
| Country | Germany |
| State | BC |
| City | Vancouver |
| Address | 1040 West Georgia Street |
| ZIP | V6E 4H1 |
| Phone | (604) 210-2217 |
| Website | https://www.achievelifesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.
Q&A For Achieve Life Sciences, Inc. Stock
What is a current SP4P.F stock price?
Achieve Life Sciences, Inc. SP4P.F stock price today per share is 4.62 EUR.
How to purchase Achieve Life Sciences, Inc. stock?
You can buy SP4P.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Achieve Life Sciences, Inc.?
The stock symbol or ticker of Achieve Life Sciences, Inc. is SP4P.F.
Which industry does the Achieve Life Sciences, Inc. company belong to?
The Achieve Life Sciences, Inc. industry is Biotechnology.
How many shares does Achieve Life Sciences, Inc. have in circulation?
The max supply of Achieve Life Sciences, Inc. shares is 35.71M.
What is Achieve Life Sciences, Inc. Price to Earnings Ratio (PE Ratio)?
Achieve Life Sciences, Inc. PE Ratio is now.
What was Achieve Life Sciences, Inc. earnings per share over the trailing 12 months (TTM)?
Achieve Life Sciences, Inc. EPS is -1.16 EUR over the trailing 12 months.
Which sector does the Achieve Life Sciences, Inc. company belong to?
The Achieve Life Sciences, Inc. sector is Healthcare.